Articles
Replicel Terminates License With Shiseido: Update (12/21/21) Two months after Replicel announced that it was entering arbitration proceedings with Shiseido, the company has announced today that it has terminated its license agreement with Shiseido. The license agreement between Replicel and Shiseido dates back to 2013 when Shiseido paid an upfront fee to gain the rights…
Read More
Histogen is finally becoming a publicly traded company in 2020 after latest merger deal. On January 28, 2020, Histogen and Conatus Pharmaceuticals issued a press release announcing a definitive merger agreement between the two companies. Like Histogen, Conatus Pharmaceuticals is a biotech company based in San Diego, CA. Conatus has been publicly traded on Nasdaq…
Read More
RT160 Gray Hair Reversal Published Study (7/13/20) Last week, a new peer-reviewed article on RiverTown Therapeutics’ RT1640 was published in the Pigment Cell & Melanoma Research journal. The study is titled “Topical RT1640 treatment effectively reverses gray hair and stem cell loss in a mouse model of radiation‐induced canities” and was led by Dr. Melissa…
Read More
2020 has started with some good news for people seeking hair regrowth treatments. HairClone announced today that they have been awarded a grant from the Innovate UK organization. This grant is government funded in the United Kingdom and is awarded to innovative technologies with the potential to make an impact on the UK economy. I’m…
Read MoreIn this article we will take a look at the most promising developments slated to occur in the hair restoration industry in 2020. Clinical Treatments And Drugs For Hair Loss In 2020 TissUse & J Hewitt – TissUse’s hair regeneration therapy is known as the Smart Hair Transplant or SHT which has been in development…
Read More
Updated 12/19/19 Today, I received an email from Follica management which shared the company’s latest press release. The company has just announced positive topline data from its FOL-004 safety and efficacy optimization study which was carried out in 2019. According to the release, the study was designed to determine the optimal treatment regimen involving Follica’s…
Read More
In this article we will take a look at the pipeline of Stemore, a new company based in Korea that is developing a wide range of hair loss treatments. Stemore was founded in 2015 by Jong Hyuk Sung, Professor of Pharmacy at Yonsei University in South Korea. Sung is an accomplished researcher and has authored…
Read MoreThe medical aesthetic giant Allergan is doubling down on its mission to cure baldness. Collaboration With Exicure Did it seem like research and development was slowing down in the hair growth treatment sector? Allergan doesn’t think so. Today, November 14, 2019, it was announced that Allergan has invested $25 million in the company Exicure to…
Read More
The anti-androgen drug Breezula is now being trialed for women with pattern hair loss. Today on November 13, 2019, the pharmaceutical company Cassiopea announced that a new phase 2 trial for female androgenic alopecia is soon to be underway. This announcement follows approval from the German BfArM (equivalent to the US FDA) to begin the…
Read More
Minoxidil Boosting Product Update (10/22/20) As we get into the last few months of 2020, I have an update to share regarding the release of the anticipated minoxidil response-enhancing product from Applied Biology. This update comes from Dr. Andy Goren, founder of Applied Biology. As a quick recap, Applied Biology is developing a product containing a…
Read More